424B5 ·Filed Jun 16, 2026

PHGE

BiomX Inc.
BEARISH
Impact 5/10
Horizonweeks Processed3mo ago SEC0001213900-26-069312
Notable filing: 424B5
Actionable Insight ▼ Bearish

The replenished ATM capacity ($5.06M) is a material dilutive risk for a $6M market cap stock. Expect continuous downward pressure as Wainwright sells into the market. Combined with the separate S-3 resale registration covering up to 5.3M shares from pre-funded warrants and convertible preferred, the total potential share overhang is severe. Short-term bearish; avoid longs until ATM activity is exhausted and share count stabilizes.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
PHGE ▲ +236.36% at T+60d
SHORT call ✗ call lost -236.36% · α vs SPY -233.22% · entry $0.5500 → $1.85
Entry anchored
Jun 16, 03:59 PM ET
via exchange tick
T+1d
-5.47%
call +5.47% · α +6.25%
$0.5199
settled 4mo ago
T+5d
-24.27%
call +24.27% · α +23.23%
$0.4165
settled 3mo ago
T+20d
-62.36%
call +62.36% · α +63.68%
$0.2070
settled 3mo ago
T+60d
+236.36%
call -236.36% · α -233.22%
$1.85
settled 22d ago

Price Chart

Loading chart...

Executive Summary

BiomX filed a prospectus supplement to update its ATM offering capacity, authorizing up to $5,061,000 in common stock sales through H.C. Wainwright. This updates prior ATM programs under the same S-3 shelf. The filing is a routine administrative update to replenish offering capacity under the shelf's I.B.6 limitations and does not represent a new primary offering. Given the micro-cap ($6M market cap) and the dilutive overhang, the incremental capacity is notable for the stock's float.

Key Facts

  • Up to $5,061,000 of common stock may be sold via ATM through H.C. Wainwright (replaces prior ATM capacity).
  • Previously sold $1,376,214 under prior supplements on the same S-3 shelf.
  • Outstanding shares: 11,797,449 as of June 16, 2026. Stock closed at $0.555/shr on June 15, 2026.
  • Market cap ~$6M; the new ATM capacity represents ~84% of current market cap (at $0.555/shr).
  • Non-affiliate public float valued at $19.25M based on $1.84 reference price from April 17, 2026.
  • 12-month prior I.B.6 sales total $1,355,841. New limit of $5,061,000 resets the available capacity.
  • The shelf also covers a separate resale registration (S-3 filed Feb 2026) for up to 5,310,933 shares from convertible preferred and warrants, creating additional potential dilution.

Financial Impact

Up to $5,061,000 in new ATM capacity — equivalent to roughly 84% of current market cap at the June 15 closing price of $0.555/shr. Overhang is significant for a micro-cap issuer.

dilutionmarketCapshareCount

Risk Factors

  • Massive potential dilution relative to current float — $5.06M ATM plus 5.3M additional shares from the S-3 resale registration.
  • ATM at-the-market sales by H.C. Wainwright likely to pressure price near the $0.555 level or lower.
  • Micro-cap with weak institutional base (top holder Morgan Stanley at ~$72K) has limited absorption capacity.
  • Historical reports on PHGE show extreme negative drift (avg T+20 -63%, 13% win rate) — consistent with sustained dilution and declining fundamentals.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001213900-26-069312
Document: 0001213900-26-069312-index-headers.html0001213900-26-069312
Document: 0001213900-26-069312-index.html0001213900-26-069312
Document: 0001213900-26-069312.txt0001213900-26-069312
20 reports for PHGE
Performance horizon
60% Hit rate 6 of 10 directional calls best @ T+20▲ +43.24%Jun 29, 2026
Filters
Rows
Reports for PHGE — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1425 $1.85▲ +1198.25%▲ +1199.20%$0.3600 (+152.63%)
Aug 28, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.1371 $0.1550▲ +13.06%▲ +13.20%$0.3600 (+162.58%)
Aug 5, 2026
8w ago
Press Release
BEARISH ★ 5/10
$0.1800 $0.1483▲ +17.61%▲ +17.96%$0.3600 (−100.00%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 28, 2026
9w ago
Press Release
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 27, 2026
9w ago
424B5
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 8, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$0.2758 $0.2100▼ −23.86%▼ −24.72%$0.3600 (+30.53%)
Jul 2, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.3190 $0.2800▲ +12.23%▲ +13.16%$0.3600 (−12.85%)
Jun 29, 2026
13w ago
S-1
BEARISH ★ 5/10
$0.3478 $0.3020▲ +13.17%▲ +13.77%$0.3600 (−3.51%)
Jun 22, 2026
14w ago
DEFA14A
NEUTRAL ★ 2/10
$0.4615 $0.3590▼ −22.21%▼ −23.22%$0.3600 (−21.99%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (33h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access